United States - English - NLM (National Library of Medicine)

apotheca company - human chorionic gonadotropin (unii: 20ed16gheb) (human chorionic gonadotropin - unii:20ed16gheb) - human chorionic gonadotropin 34 [hp_c] in 1 ml - indications:   supports weight loss by regulating male and female hormone functions and also by suppressing ravenous appetite. indications: supports weight loss by regulating male and female hormone functions and also by suppressing ravenous appetite.

Australia - English - Department of Health (Therapeutic Goods Administration)

revvity pty ltd - ct856 - human chorionic gonadotropin (hcg) ivds - ivds that are intended to be used for the qualititative and/or quantitative determination of human chorionic gonadotropin (hcg) hormone and its various forms in a clinical specimen.

United States - English - NLM (National Library of Medicine)

apotheca company - human chorionic gonadotropin (unii: 20ed16gheb) (human chorionic gonadotropin - unii:20ed16gheb) - human chorionic gonadotropin 200 [hp_c] in 1 ml - indications:   supports weight loss by regulating male and female hormone functions and also suppressing ravenous appetite.

Israel - English - Ministry of Health

merck serono ltd - luteinizing hormone - powder for solution for injection - luteinizing hormone 75 iu/ml - gonadotropins - luveris in association with a follicle stimulating hormone (fsh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level < 1.2 iu/l.

Ireland - English - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals ltd - leuprorelin acetate - powder and solvent for suspension for injection - 22.5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - it t is indicated for palliative treatment of hormone dependent advanced prostate cancer

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - choriogonadotropin alfa 250ug; choriogonadotropin alfa 250ug - solution for injection - 250 mcg/0.5ml - active: choriogonadotropin alfa 250ug excipient: mannitol methionine phosphoric acid poloxamer sodium hydroxide water for injection active: choriogonadotropin alfa 250ug excipient: dibasic sodium phosphate dihydrate mannitol methionine phosphoric acid poloxamer sodium hydroxide sodium phosphate water for injection - anovulatory or oligo-ovulatory women: ovidrel is administered to trigger ovulation and luteinisation in anovulatory or oligo-ovulatory patients after stimulation of follicular growth.

Israel - English - Ministry of Health

merck serono ltd - follitropin alfa - solution for injection - follitropin alfa 600 iu/ml - follitropin alfa - follitropin alfa - in adult women:• anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate.• stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift).• follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level < 1.2 iu/l.in adult men:• follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.

European Union - English - EMA (European Medicines Agency)

gedeon richter plc. - follitropin alfa - anovulation - sex hormones and modulators of the genital system, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level < 1.2 iu/l.in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.

European Union - English - EMA (European Medicines Agency)

merck europe b.v. - follitropin alfa - anovulation; reproductive techniques, assisted; infertility, female; hypogonadism - sex hormones and modulators of the genital system, - anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate.stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in-vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift).gonal-f in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level

European Union - English - EMA (European Medicines Agency)

theramex ireland limited - follitropin alfa - anovulation - sex hormones and modulators of the genital system, - in adult womenanovulation (including polycystic ovarian syndrome) in women who have been unresponsive to treatment with clomifene citrate;stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer and zygote intra-fallopian transfer;ovaleap in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level < 1.2 iu/l.in adult menovaleap is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotropic hypogonadism with concomitant human chorionic gonadotropin (hcg) therapy.